Syngene International Ltd.: Share Price, Stock Analysis, Annual Report | Value Research Get Syngene International Ltd.'s stock analysis, price valuation, corporate actions, and financials from India's independent mutual fund research house.
info-circle
SYNGENE

Click to see a quick summary and important updates about this stock!Dismiss

Syngene International Ltd.

BSE: 539268, NSE: SYNGENE

  • Market Capitalisation info

    ₹24,126 Cr


  • 12 Month Earnings info

    ₹428 Cr

  • Price to Earnings info

    56.41

₹600.80

As on 29-Nov-2022 IST

up-down-arrow-1.80-0.30%

  • Prev Close info

    602.60

  • Day's Openinfo

    604.95

  • Today's Highinfo

    607.80

  • Today's Lowinfo

    593.20

  • Today's Volumeinfo

    3,78,282

Please wait...

Stock Performance

YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Syngene International
-3.08 -2.02 0.12 1.87 24.07 17.46 --
S&P BSE Healthcare
-8.98 0.90 4.86 -6.93 20.37 11.19 11.77
S&P BSE Mid Cap
2.84 2.52 2.23 3.35 19.47 8.55 14.31
As on 29-Nov-2022
2021
2020
2019
2018
2017
2016
Syngene International
-1.97 98.45 14.86 2.25 -3.65 34.51
S&P BSE Mid Cap
39.18 19.87 -3.05 -13.31 48.13 7.97
S&P BSE Healthcare
20.87 61.45 -3.55 -5.89 0.49 -12.88

Valuation

Stock
Peer Median
Please wait...

Growth & Efficiency

Stock
Peer Median
Please wait...

Solvency

Is there a threat to this company's solvency in the future?

Financial Manipulation

Can creative accounting be detected through the financial numbers?

Peer Comparison

search
search
search
search
    Please wait...

    Valuation Chart

      Please wait...
        Please wait...

        Financials

        Please wait...
        Please wait...
        Please wait...

        Shareholding Pattern

        News & Analysis

        Other Details

        Incorporated

        1993

        Chairman

        Kiran Mazumdar Shaw

        Managing Director

        Jonathan Hunt

        Headquarters

        Bengaluru, Karnataka
        Edit edit
        Please wait...
        Please wait...
        Please wait...
        Please wait...

        Key Facts

        • Market cap info

          ₹24,126.21 Cr

        • Revenue (TTM) info

          ₹2,812.10 Cr

        • Earnings (TTM) info

          ₹427.70 Cr

        • Cash info

          ₹1,104.30 Cr

        • Total Debt info

          ₹789.60 Cr

        • Promoters' ownership info

          64.86%

        • Liquidity info

          High

        • 52 Week range info

          ₹510.05 - 683.00

        • Face value info

          ₹10.00

        • Shares outstanding info

          40,14,34,500

        • 10 Years Aggregate:

          CFO: ₹4,170.30 Cr

          EBITDA: ₹4,346.90 Cr

          Net Profit: ₹2,784.40 Cr

        About The Company

        • Business

          Scientific research and development

        • Incorporated

          1993

        • Chairman

          Kiran Mazumdar Shaw

        • Managing Director

          Jonathan Hunt

        • Listing info

          BSE: 539268, NSE: SYNGENE

        • Country

          India

        • Headquarters info

          Bengaluru, Karnataka

        • Website info

          www.syngeneintl.com